Compare J.B.Chemicals with Sun Pharma - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

J.B.CHEMICALS vs SUN PHARMA - Comparison Results

J.B.CHEMICALS     Change

JB Chemicals and Pharmaceuticals Limited (JBCPL), the flagship of the Unique Group, is one of the India's leading transnational pharmaceutical company. The company has 11 manufacturing facilities at four locations in India (Belapur, Ankleshwar, Panol... More

SUN PHARMA 
   Change

Sun Pharma holds 3.7% share of the domestic pharma market (as per the latest ORG IMS MAT data) and has a strong presence in the lifestyle therapeutic segments. The company started focusing on the exports market in FY02, when it increased its stake to... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    J.B.CHEMICALS SUN PHARMA J.B.CHEMICALS/
SUN PHARMA
 
P/E (TTM) x 22.9 27.2 84.2% View Chart
P/BV x 4.1 2.8 149.8% View Chart
Dividend Yield % 0.3 0.6 49.1%  

Financials

 J.B.CHEMICALS   SUN PHARMA
EQUITY SHARE DATA
    J.B.CHEMICALS
Mar-18
SUN PHARMA
Mar-19
J.B.CHEMICALS/
SUN PHARMA
5-Yr Chart
Click to enlarge
High Rs363679 53.5%   
Low Rs255375 67.9%   
Sales per share (Unadj.) Rs169.1121.1 139.6%  
Earnings per share (Unadj.) Rs16.613.4 124.1%  
Cash flow per share (Unadj.) Rs23.420.7 113.2%  
Dividends per share (Unadj.) Rs2.002.75 72.7%  
Dividend yield (eoy) %0.60.5 124.0%  
Book value per share (Unadj.) Rs172.5172.6 99.9%  
Shares outstanding (eoy) m83.572,399.26 3.5%   
Bonus/Rights/Conversions BB--  
Price / Sales ratio x1.84.4 42.0%   
Avg P/E ratio x18.639.4 47.2%  
P/CF ratio (eoy) x13.225.5 51.8%  
Price / Book Value ratio x1.83.1 58.7%  
Dividend payout %12.020.6 58.6%   
Avg Mkt Cap Rs m25,8271,264,650 2.0%   
No. of employees `0003.817.5 21.6%   
Total wages/salary Rs m2,51159,671 4.2%   
Avg. sales/employee Rs Th3,747.416,608.1 22.6%   
Avg. wages/employee Rs Th665.73,409.6 19.5%   
Avg. net profit/employee Rs Th367.81,833.8 20.1%   
INCOME DATA
Net Sales Rs m14,135290,659 4.9%  
Other income Rs m36610,255 3.6%   
Total revenues Rs m14,501300,914 4.8%   
Gross profit Rs m2,17863,076 3.5%  
Depreciation Rs m57017,533 3.2%   
Interest Rs m355,553 0.6%   
Profit before tax Rs m1,94050,246 3.9%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m0-12,144 0.0%   
Tax Rs m5526,009 9.2%   
Profit after tax Rs m1,38732,093 4.3%  
Gross profit margin %15.421.7 71.0%  
Effective tax rate %28.512.0 238.1%   
Net profit margin %9.811.0 88.9%  
BALANCE SHEET DATA
Current assets Rs m10,470310,692 3.4%   
Current liabilities Rs m2,749173,396 1.6%   
Net working cap to sales %54.647.2 115.6%  
Current ratio x3.81.8 212.6%  
Inventory Days Days5599 55.7%  
Debtors Days Days78112 69.6%  
Net fixed assets Rs m5,811232,477 2.5%   
Share capital Rs m1672,399 7.0%   
"Free" reserves Rs m14,248411,691 3.5%   
Net worth Rs m14,416414,091 3.5%   
Long term debt Rs m015,226 0.0%   
Total assets Rs m17,649646,938 2.7%  
Interest coverage x56.610.0 563.0%   
Debt to equity ratio x00 0.0%  
Sales to assets ratio x0.80.4 178.3%   
Return on assets %8.15.8 138.5%  
Return on equity %9.67.8 124.2%  
Return on capital %13.710.2 134.7%  
Exports to sales %00-   
Imports to sales %00-   
Exports (fob) Rs mNANA-   
Imports (cif) Rs mNANA-   
Fx inflow Rs m6,16466,025 9.3%   
Fx outflow Rs m1,33438,610 3.5%   
Net fx Rs m4,82927,415 17.6%   
CASH FLOW
From Operations Rs m1,23121,965 5.6%  
From Investments Rs m-208-6,813 3.1%  
From Financial Activity Rs m-595-27,305 2.2%  
Net Cashflow Rs m427-8,442 -5.1%  

Share Holding

Indian Promoters % 55.4 63.7 87.0%  
Foreign collaborators % 0.3 0.0 -  
Indian inst/Mut Fund % 3.4 5.1 66.1%  
FIIs % 3.9 23.0 17.0%  
ADR/GDR % 0.0 0.0 -  
Free float % 37.0 8.3 445.8%  
Shareholders   30,437 133,026 22.9%  
Pledged promoter(s) holding % 0.0 0.5 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare J.B.CHEMICALS With:   DR. REDDYS LAB  IPCA LABS  ASTRAZENECA PHARMA  AUROBINDO PHARMA  PIRAMAL ENTERPRISES  

Compare J.B.CHEMICALS With:   ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  MYLAN (US)  TEVA PHARMA (Israel)  



Today's Market

Indian Indices Continue Momentum; Sensex Ends 522 Points Higher(Closing)

Indian share markets witnessed positive trading activity throughout the day today and ended on a strong note.

Related Views on News

SUN PHARMA Announces Quarterly Results (4QFY20); Net Profit Down 31.6% (Quarterly Result Update)

May 28, 2020 | Updated on May 28, 2020

For the quarter ended March 2020, SUN PHARMA has posted a net profit of Rs 5 bn (down 31.6% YoY). Sales on the other hand came in at Rs 82 bn (up 14.3% YoY). Read on for a complete analysis of SUN PHARMA's quarterly results.

SUN PHARMA Announces Quarterly Results (3QFY20); Net Profit Down 29.8% (Quarterly Result Update)

Feb 7, 2020 | Updated on Feb 7, 2020

For the quarter ended December 2019, SUN PHARMA has posted a net profit of Rs 10 bn (down 29.8% YoY). Sales on the other hand came in at Rs 82 bn (up 5.4% YoY). Read on for a complete analysis of SUN PHARMA's quarterly results.

J.B.CHEMICALS Announces Quarterly Results (3QFY20); Net Profit Up 34.1% (Quarterly Result Update)

Feb 6, 2020 | Updated on Feb 6, 2020

For the quarter ended December 2019, J.B.CHEMICALS has posted a net profit of Rs 622 m (up 34.1% YoY). Sales on the other hand came in at Rs 4 bn (up 9.3% YoY). Read on for a complete analysis of J.B.CHEMICALS's quarterly results.

SUN PHARMA Announces Quarterly Results (1QFY20); Net Profit Up 35.3% (Quarterly Result Update)

Aug 14, 2019 | Updated on Aug 14, 2019

For the quarter ended June 2019, SUN PHARMA has posted a net profit of Rs 15 bn (up 35.3% YoY). Sales on the other hand came in at Rs 84 bn (up 15.9% YoY). Read on for a complete analysis of SUN PHARMA's quarterly results.

SUN PHARMA 2018-19 Annual Report Analysis (Annual Result Update)

Aug 6, 2019 | Updated on Aug 6, 2019

Here's an analysis of the annual report of SUN PHARMA for 2018-19. It includes a full income statement, balance sheet and cash flow analysis of SUN PHARMA. Also includes updates on the valuation of SUN PHARMA.

More Views on News

Most Popular

6 Charts Showing the State of Indian Financial Markets in 2020(Sector Info)

May 26, 2020

Six charts showing how Indian financial markets have performed in 2020 so far...

What the RBI's Rate Cut Means for Options Traders(Fast Profits Daily)

May 25, 2020

The RBI governor has cut the repo rate to 4%. What does this mean for options traders? Find out in this video.

Which Stocks Should You Buy, Sell, and Hold in the Market Today?(Profit Hunter)

May 21, 2020

The coronavirus led uncertainty refuses to go away from the markets. Here's what retail investors should do with their stocks...

Why We Picked This Smallcap Stock for a Post Coronavirus World(Profit Hunter)

May 28, 2020

Covid-19 has made it a survival of the fittest race for many companies. The ones that can adapt will thrive in a post crisis world.

More

India's #1 Trader
Reveals His Secrets

The Secret to Increasing Your Trading Profits Today
Get this Special Report, The Secret to Increasing Your Trading Profits Today, Now!
We will never sell or rent your email id.
Please read our Terms

J.B.CHEMICALS SHARE PRICE


Jun 2, 2020 (Close)

TRACK J.B.CHEMICALS

  • Track your investment in J.B.CHEMICALS with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

J.B.CHEMICALS - CADILA HEALTHCARE COMPARISON

COMPARE J.B.CHEMICALS WITH

MARKET STATS